Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Sees Significant Drop in Short Interest

Bullfrog AI Holdings, Inc. (NASDAQ:BFRGGet Free Report) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 286,000 shares, a decrease of 47.4% from the February 28th total of 543,400 shares. Based on an average daily trading volume, of 846,100 shares, the days-to-cover ratio is presently 0.3 days. Approximately 4.3% of the company’s shares are short sold.

Institutional Trading of Bullfrog AI

Large investors have recently modified their holdings of the stock. Raymond James Financial Inc. bought a new position in Bullfrog AI during the fourth quarter worth $30,000. Geode Capital Management LLC increased its stake in Bullfrog AI by 31.0% in the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after purchasing an additional 11,140 shares in the last quarter. Finally, Two Sigma Securities LLC acquired a new position in shares of Bullfrog AI during the fourth quarter valued at about $41,000. Institutional investors and hedge funds own 0.96% of the company’s stock.

Bullfrog AI Stock Down 6.1 %

BFRG stock opened at $1.70 on Friday. The firm has a market cap of $16.01 million, a price-to-earnings ratio of -2.00 and a beta of 0.32. The company’s fifty day simple moving average is $2.37 and its 200 day simple moving average is $2.37. Bullfrog AI has a 12-month low of $1.43 and a 12-month high of $4.84.

Bullfrog AI (NASDAQ:BFRGGet Free Report) last announced its earnings results on Friday, March 14th. The company reported ($0.18) EPS for the quarter.

About Bullfrog AI

(Get Free Report)

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.

Recommended Stories

Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.